These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine. Bonnet AM; Serre I; Marconi R; Agid Y; Dubois B Mov Disord; 1995 Sep; 10(5):668-71. PubMed ID: 8552122 [TBL] [Abstract][Full Text] [Related]
7. Comparison between lergotrile and bromocriptine in parkinsonism. Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273 [TBL] [Abstract][Full Text] [Related]
8. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients]. Frattola L; Albizzati MG; Spano PF; Trabucchi M Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891 [No Abstract] [Full Text] [Related]
10. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations. de la Fuente-Fernández R Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251 [TBL] [Abstract][Full Text] [Related]
13. A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease. Ho B; Prakash R; Morgan JC; Sethi KD Nat Clin Pract Neurol; 2007 Sep; 3(9):526-30. PubMed ID: 17805247 [TBL] [Abstract][Full Text] [Related]
14. Comparison of pergolide and bromocriptine therapy in parkinsonism. LeWitt PA; Ward CD; Larsen TA; Raphaelson MI; Newman RP; Foster N; Dambrosia JM; Calne DB Neurology; 1983 Aug; 33(8):1009-14. PubMed ID: 6348585 [TBL] [Abstract][Full Text] [Related]
15. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias. Mark MH; Sage JI Ann Clin Lab Sci; 1994; 24(1):12-21. PubMed ID: 8147565 [TBL] [Abstract][Full Text] [Related]
16. A family with hereditary juvenile dystonia-parkinsonism. Ishikawa A; Miyatake T Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830 [TBL] [Abstract][Full Text] [Related]
17. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340 [TBL] [Abstract][Full Text] [Related]
18. Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa. Rinne UK; Marttila R Ann Neurol; 1978 Sep; 4(3):263-7. PubMed ID: 718139 [TBL] [Abstract][Full Text] [Related]
19. Pergolide in the treatment of Parkinson's disease. Mear JY; Barroche G; de Smet Y; Weber M; Lhermitte F; Agid Y Neurology; 1984 Jul; 34(7):983-6. PubMed ID: 6539880 [TBL] [Abstract][Full Text] [Related]
20. Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia. Furukawa Y; Mizuno Y; Narabayashi H Adv Neurol; 1996; 69():327-37. PubMed ID: 8615147 [No Abstract] [Full Text] [Related] [Next] [New Search]